CHA2DS2-VASc-HSF Score may Better Predict the Development of Total Coronary Artery Occlusion in Acute Coronary Syndrome

Abstract

Get full access to this article

View all access options for this article.

References

Yaşar

Bayramoğlu

Karakuş

Çakmak

. The CHA2DS2-VASc risk score predicts total occlusion in infarct-related arteries in patients with non-ST elevation myocardial infarction. Angiology 2021. DOI: 10.1177/00033197211031324.

January

Wann

Alpert

, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol 2014; 64: 1-76.

Lip

Nieuwlaat

Pisters

Lane

Crijns

. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-72.

Kurtul

Acikgoz

. Validation of the CHA2DS2-VASc score in predicting coronary atherosclerotic burden and In-hospital mortality in patients with acute coronary syndrome. Am J Cardiol 2017; 120: 8-14.

Kurtul

Yarlioglues

Duran

. Predictive value of CHA2DS2-VASC score for contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 2017; 119: 819-825.

Mirbolouk

Gholipour

Salari

, et al. CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. J Cardiovasc Thorac Res 2018; 10: 46-52.

Kurtul

. Usefulness of the CHA2DS2-VASc score in predicting in-stent restenosis among patients undergoing revascularization with bare-metal stents. Clin Appl Thromb Hemost 2018; 24: 589-95.

Tanık

Aruğaslan

Çinar

Keskin

Kaya

Tekkeşin

. Association of the CHA2DS2VASc score with acute stent thrombosis in patients with an ST elevation myocardial infarction who underwent a primary percutaneous coronary intervention. Med Princ Pract 2019; 28: 115-23.

Węgiel

Rakowski

Dziewierz

, et al. CHA2DS2-VASc and R2-CHA2DS2-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction. Postepy Kardiol Interwencyjnej 2018; 14: 391-8.

10.

Modi

Patted

Halkati

, et al. CHA2DS2-VASc-HSF score-New predictor of severity of coronary artery disease in 2976 patients. Int J Cardiol 2017; 228: 1002-6.

11.

Andrianto

Jovie

Al-Farabi

Gandi

Shonafi

Lathifah

. Novel CHA2DS2-VASc-HSF is Superior to CHADS2 and CHA2DS2-VAScScore to predict the risk of severe coronary artery disease. Macedonian J Med Sci 2020; 8: 451-6.

12.

Zhang

Sun

. New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. BMC Cardiovasc Disord 2020; 20: 346.

13.

Kalyoncuoğlu

Durmuş

Belen

Can

. Predictive accuracy of the CHA2DS2-VASc-HSF score in determining one-year cardiovascular outcomes in patients with non-ST-elevation acute coronary syndrome: A retrospective study. Koşuyolu Heart J 2020; 23: 27-37.